Patents by Inventor Jacques Luyckx

Jacques Luyckx has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100069315
    Abstract: The invention relates to a method for treating ocular infections, by topical application twice a day in each eye to be treated, for less than four days, of a medicament essentially consisting of azithromycin in solution in a pharmaceutically acceptable vehicle of linear medium-chain fatty acid triglycerides, at the concentration of 1% to 2%.
    Type: Application
    Filed: September 8, 2009
    Publication date: March 18, 2010
    Inventors: Jacques Luyckx, Frederic Pilotaz, Pablo Goldschmidt
  • Publication number: 20060252711
    Abstract: The invention relates to a method for treating ocular infections, by topical application twice a day in each eye to be treated, for less than four days, of a medicament essentially consisting of azithromycin in solution in a pharmaceutically acceptable vehicle of linear medium-chain fatty acid triglycerides, at the concentration of 1% to 2%.
    Type: Application
    Filed: April 21, 2006
    Publication date: November 9, 2006
    Inventors: Jacques Luyckx, Frederic Pilotaz, Pablo Goldschmidt
  • Patent number: 7064109
    Abstract: The invention relates to a pharmaceutical composition for preventing and/or treating eye infections, which is to be used by local application. It is in particular directed towards such a composition which is in the form of an eye lotion which can be distributed by drops, in which an antibiotic of the macrolide class, such as azithromycin, is in solution in an oily vehicle. This vehicle is, in particular, of the type of product essentially consisting of medium-chain triglycerides in which the alcohol functions of the glycerol are entirely esterified by carboxylic acids made from saturated hydrocarbons, the molecule of which comprises from 5 to 12 carbon atoms. They are preferably linear-chain fatty acids comprising from 8 to 10 carbon atoms, such as caprylic acid or capric acid. The composition is advantageously prepared by dissolving the active agent in the oily vehicle at a temperature not exceeding 70° C.
    Type: Grant
    Filed: April 11, 2002
    Date of Patent: June 20, 2006
    Assignee: Laboratories Thea
    Inventors: Jacques Luyckx, Frederic Pilotaz
  • Publication number: 20040197340
    Abstract: The invention relates to a pharmaceutical composition for preventing and/or treating eye infections, which is to be used by local application. It is in particular directed towards such a composition which is in the form of an eye lotion which can be distributed by drops, in which an antibiotic of the macrolide class, such as azithromycin, is in solution in an oily vehicle. This vehicle is, in particular, of the type of product essentially consisting of medium-chain triglycerides in which the alcohol functions of the glycerol are entirely esterified by carboxylic acids made from saturated hydrocarbons, the molecule of which comprises from 5 to 12 carbon atoms. They are preferably linear-chain fatty acids comprising from 8 to 10 carbon atoms, such as caprylic acid or capric acid. The composition is advantageously prepared by dissolving the active agent in the oily vehicle at a temperature not exceeding 70° C.
    Type: Application
    Filed: May 12, 2004
    Publication date: October 7, 2004
    Inventors: Jacques Luyckx, Frederic Pilotaz
  • Patent number: 6336571
    Abstract: The invention concerns a device comprising a flask (1) with variable internal volume having a rigid neck (5) wherein is arranged the body (3) of a dispensing head (2) ending in a conduit (41) discharging the liquid and containing a microporous pad (6) for generating a head loss regulating the liquid flow pushed therethrough into a distribution chamber (31) communicating with said conduit. The pad is advantageously made of a material inert with respect to the liquid and combined with an antibacterial filtering element (9) preventing outside air from entering the flask. It evenly occupies the body (3) over the whole cross-section of the liquid passage.
    Type: Grant
    Filed: May 3, 2000
    Date of Patent: January 8, 2002
    Assignee: Laboratoires Thea S.A.
    Inventors: Henri Chibret, Michel Faurie, Jacques Luyckx, Alain Defemme, Thierry Coquel
  • Patent number: 5585116
    Abstract: Osteoplasty material substantially devoid of antigenic proteins, wherein the material contains a natural bone structure in which non-denatured type I collagen is integrated, is prepared by selective extraction of bone tissue of human or animal origin. The selective extractant is an aqueous solution of 2-10 molar urea, and the extraction step is conducted at preferably 10.degree.-30.degree. C.
    Type: Grant
    Filed: February 3, 1995
    Date of Patent: December 17, 1996
    Assignee: OST-Developpment
    Inventors: Robert Boniface, Michel Faurie, Pablo Goldschmidt, Jean-Pierre Lontrade, Jacques Luyckx